HIFU: A newer option for men with localized prostate cancer Richard Ridington If you're considering treatments for localized prostate cancer, there’s one option you may not know of: High Intensity Focused Ultrasound (HIFU). I am not a medical professional, but one patient who can say why he found HIFU an appealing choice, then suggest some [...]
Erleada (apalutamide) has just received FDA approval as a drug for treating men with non-metastatic castration-resistant prostate cancer. The proper pronunciation is Er ( Errr), (Like Her without the h) ) (lee) (long E) da. Now, repeat after me, "Erleada!" It's a pill that you take - I believe - four times a [...]
Men with Prostate Cancer May Not Know All Of Their Treatment Options and Risks by Brian Miles, MD Urology Houston Methodist Urology Associates Professor of Urology, Institute for Academic Medicine Houston Methodist - Weill Cornell Medical College According to a September 2017 study by BJU International, men who have been diagnosed with localized prostate [...]
Rather than taking – and paying – for the full Zytiga dose on an empty stomach, ask your doctor if you could get the same effect from taking just one fourth of your Zytiga dose while enjoying a low-fat or high-fat breakfast. A small phase two study of 36 prostate cancer patients who took 250 [...]
One of the hot topics in the prostate cancer community is the value of detecting AR-V7 tumor cells circulating in the blood. AR-V7 tumor cells in the blood predicts response or failure of treatment with enzalutamide (Xtandi) or abiraterone (Zytiga). A recent study found that men who have AR-V7 circulating tumor cells in their blood will not [...]